Troglitazone, a thiazolidinedione, decreases tau phosphorylation through the inhibition of cyclin-dependent kinase 5 activity in SH-SY5Y neuroblastoma cells and primary neurons
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Troglitazone, a thiazolidinedione, decreases tau phosphorylation through the inhibition of cyclin-dependent kinase 5 activity in SH-SY5Y neuroblastoma cells and primary neurons
Authors
Keywords
-
Journal
JOURNAL OF NEUROCHEMISTRY
Volume 126, Issue 5, Pages 685-695
Publisher
Wiley
Online
2013-04-13
DOI
10.1111/jnc.12264
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Peroxisome Proliferator-Activated Receptor-γ (PPAR-γ) Agonists on Glycemic Control, Lipid Profile and Cardiovascular Risk
- (2012) Giuseppe Derosa et al. Current Molecular Pharmacology
- Cyclin-Dependent Kinases in Brain Development and Disease
- (2011) Susan C. Su et al. Annual Review of Cell and Developmental Biology
- Rosiglitazone Improves Spatial Memory and Decreases Insoluble Aβ1–42 in APP/PS1 Mice
- (2011) Julie-Ann O’Reilly et al. Journal of Neuroimmune Pharmacology
- The ε3 and ε4 Alleles of Human APOE Differentially Affect Tau Phosphorylation in Hyperinsulinemic and Pioglitazone Treated Mice
- (2011) Alvina W. M. To et al. PLoS One
- Modulation of aberrant CDK5 signaling rescues impaired neurogenesis in models of Alzheimer's disease
- (2011) L Crews et al. Cell Death & Disease
- Cdk5, the multifunctional surveyor
- (2010) Vassiliki Lalioti et al. CELL CYCLE
- TAU Aggregation is a Therapeutic Target for Alzheimers Disease
- (2010) A. Takashima Current Alzheimer Research
- Tau in Alzheimer Disease and Related Tauopathies
- (2010) K. Iqbal et al. Current Alzheimer Research
- Cyclin-Dependent Kinase Inhibitors as Anticancer Drugs
- (2010) Vladimir Krystof et al. CURRENT DRUG TARGETS
- Cyclin-Dependent Kinase 5 Phosphorylates Endothelial Nitric Oxide Synthase at Serine 116
- (2010) Du-Hyong Cho et al. HYPERTENSION
- The combination of sirolimus and rosiglitazone produces a renoprotective effect on diabetic kidney disease in rats
- (2010) Maria Flaquer et al. LIFE SCIENCES
- Rosiglitazone reduces tau phosphorylation via JNK inhibition in the hippocampus of rats with type 2 diabetes and tau transfected SH-SY5Y cells
- (2010) Seung-Yong Yoon et al. NEUROBIOLOGY OF DISEASE
- Rosiglitazone Rescues Memory Impairment in Alzheimer's Transgenic Mice: Mechanisms Involving a Reduced Amyloid and Tau Pathology
- (2010) Luis Escribano et al. NEUROPSYCHOPHARMACOLOGY
- Protection of synapses against Alzheimer's-linked toxins: Insulin signaling prevents the pathogenic binding of Aβ oligomers
- (2009) Fernanda G. De Felice et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tau phosphorylation: the therapeutic challenge for neurodegenerative disease
- (2009) Diane P. Hanger et al. TRENDS IN MOLECULAR MEDICINE
- Making a neuron: Cdk5 in embryonic and adult neurogenesis
- (2009) Sebastian Jessberger et al. TRENDS IN NEUROSCIENCES
- Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease
- (2008) Wei-Qin Zhao et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Peroxisome Proliferator-Activated Receptor Pathway Targeting in Carcinogenesis: Implications for Chemoprevention
- (2008) F. Ondrey CLINICAL CANCER RESEARCH
- Hyperphosphorylation of Microtubule-Associated Protein Tau: A Promising Therapeutic Target for Alzheimer Disease
- (2008) C.-X. Gong et al. CURRENT MEDICINAL CHEMISTRY
- A Novel Mechanism by Which Thiazolidinediones Facilitate the Proteasomal Degradation of Cyclin D1 in Cancer Cells
- (2008) Shuo Wei et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PPARγ agonists as therapeutics for the treatment of Alzheimer’s disease
- (2008) Gary Landreth et al. Neurotherapeutics
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started